{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:06:14Z","timestamp":1772942774788,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacl.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:33:49Z","timestamp":1718422429000},"page":"e855-e866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-2584","authenticated-orcid":false,"given":"Ben","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Rane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5655-0886","authenticated-orcid":false,"given":"Mary","family":"Finnegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-8665","authenticated-orcid":false,"given":"Rebecca","family":"Quest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Abdel-Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Biasiolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shalhoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alun","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Loyse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-4563","authenticated-orcid":false,"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-0954","authenticated-orcid":false,"given":"Kausik K","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaimini","family":"Cegla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jacl.2024.06.004_bib0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","article-title":"Global burden of stroke","volume":"120","author":"Feigin","year":"2017","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.004_bib0002","first-page":"34","article-title":"Why is the management of asymptomatic carotid disease so controversial?","volume":"13","author":"Naylor","year":"2015","journal-title":"Surg"},{"key":"10.1016\/j.jacl.2024.06.004_bib0003","doi-asserted-by":"crossref","unstructured":"Meschia J.F., Bushnell C., Boden-Albala B., et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2014;45(12):3754\u2013832. doi: 10.1161\/STR.0000000000000046 [published Online First: 20141028]","DOI":"10.1161\/STR.0000000000000046"},{"issue":"3","key":"10.1016\/j.jacl.2024.06.004_bib0004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/STROKEAHA.112.671461","article-title":"One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events","volume":"44","author":"Balestrini","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jacl.2024.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/STROKEAHA.108.532218","article-title":"Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis","volume":"40","author":"de Weerd","year":"2009","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jacl.2024.06.004_bib0006","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.14.7.1098","article-title":"Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"14","author":"Sharrett","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"19","key":"10.1016\/j.jacl.2024.06.004_bib0007","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.jacc.2012.08.986","article-title":"Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins","volume":"60","author":"Dias","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacl.2024.06.004_bib0008","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jacc.2014.03.018","article-title":"Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab","volume":"63","author":"Koren","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.jacl.2024.06.004_bib0009","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.4030","article-title":"Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial","volume":"311","author":"Robinson","year":"2014","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.jacl.2024.06.004_bib0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.03.019","article-title":"Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab","volume":"63","author":"Stroes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9965","key":"10.1016\/j.jacl.2024.06.004_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"9965","key":"10.1016\/j.jacl.2024.06.004_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jacl.2024.06.004_bib0013","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jacl.2024.06.004_bib0014","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.jacl.2024.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.06.004_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2018.08.033","article-title":"T2 mapping MRI technique quantifies carotid plaque lipid, and its depletion after statin initiation, following acute myocardial infarction","volume":"279","author":"Alkhalil","year":"2018","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.004_bib0017","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mrm.24142","article-title":"DANTE-prepared pulse trains: a novel approach to motion-sensitized and motion-suppressed quantitative magnetic resonance imaging","volume":"68","author":"Li","year":"2012","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.1016\/j.jacl.2024.06.004_bib0018","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.14131717","article-title":"Black-blood multicontrast imaging of carotid arteries with DANTE-prepared 2D and 3D MR imaging","volume":"273","author":"Li","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.004_bib0019","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1532-429X-15-69","article-title":"In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components","volume":"15","author":"Biasiolli","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"10.1016\/j.jacl.2024.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000028591.44554.F9","article-title":"Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2024.06.004_bib0021","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","author":"Barnett","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.004_bib0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jmri.22014","article-title":"Scan-rescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3T","volume":"31","author":"Li","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"10.1016\/j.jacl.2024.06.004_bib0023","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcmg.2011.06.013","article-title":"MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course","volume":"4","author":"Zhao","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"25","key":"10.1016\/j.jacl.2024.06.004_bib0024","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.119.043826","article-title":"Effect of alirocumab on stroke in odyssey outcomes","volume":"140","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.jacl.2024.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.jacc.2023.08.019","article-title":"Concomitant coronary atheroma regression and stabilization in response to lipid-lowering therapy","volume":"82","author":"Biccir\u00e8","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10438","key":"10.1016\/j.jacl.2024.06.004_bib0026","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(24)00413-6","article-title":"Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial","volume":"403","author":"Park","year":"2024","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jacl.2024.06.004_bib0027","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/01.CIR.0000041255.88750.F0","article-title":"Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging","volume":"106","author":"Corti","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2024.06.004_bib0028","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ahj.2007.11.018","article-title":"Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial","volume":"155","author":"Underhill","year":"2008","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.jacl.2024.06.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014229","article-title":"Magnetic resonance imaging of intraplaque hemorrhage and plaque lipid content with continued lipid-lowering therapy: results of a magnetic resonance imaging substudy in AIM-HIGH","volume":"15","author":"Zhao","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jacl.2024.06.004_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072256","article-title":"Effects of evolocumab on carotid intima-media thickness and clinical parameters in patients taking a statin","volume":"9","author":"Hirai","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2024.06.004_bib0031","article-title":"Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): a prospective single-arm, open-label study","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jacl.2024.06.004_bib0032","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10554-020-02115-w","article-title":"Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab","volume":"37","author":"Sun","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacl.2024.06.004_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.05.008","article-title":"Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: a time course study","volume":"327","author":"Lepor","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.004_bib0034","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1002\/ccd.29743","article-title":"CARotid plaqUe StabilizatiOn and regression with evolocumab: rationale and design of the CARUSO study","volume":"98","author":"Aranzulla","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.jacl.2024.06.004_bib0035","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.jcmg.2019.06.022","article-title":"PCSK9 antibody alirocumab attenuates arterial wall inflammation without changes in circulating inflammatory markers","volume":"12","author":"Hoogeveen","year":"2019","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:33:02Z","timestamp":1732620782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1933287424002058"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.06.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}